Back to company

SOPHION BIOSCIENCE A/S: Financial statements 2015

CVR: 10021065

SOPHION BIOSCIENCE A/S (CVR 10021065) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 87,841,000 and a net result of DKK 8,732,000. The profit margin was 9.9%. Equity amounted to DKK 124,415,000. The solvency ratio was 85.1%.

Revenue
87,841,000 kr.
Gross Profit
56,015,000 kr.
Profit/Loss
8,732,000 kr.
Equity
124,415,000 kr.
Total Assets
146,275,000 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201587.8 mio.56 mio.8.7 mio.124.4 mio.-
201383.4 mio.54 mio.18.3 mio.105.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2015

Carsten Kronsbjerg Faltum joins the board of SOPHION BIOSCIENCE A/SJul 13, 2015

As of July 13, 2015, Carsten Kronsbjerg Faltum has joined the board of directors of SOPHION BIOSCIENCE A/S.

Morten Sunesen leaves the board of SOPHION BIOSCIENCE A/SJul 13, 2015

As of July 13, 2015, Morten Sunesen has left the board of directors of SOPHION BIOSCIENCE A/S.

Carsten Kronsbjerg Faltum joins SOPHION BIOSCIENCE A/S as adm. dir.Jul 6, 2015

As of July 6, 2015, Carsten Kronsbjerg Faltum is registered as adm. dir. of SOPHION BIOSCIENCE A/S.

Morten Sunesen steps down as adm. dir. of SOPHION BIOSCIENCE A/SJul 6, 2015

As of July 6, 2015, Morten Sunesen has stepped down as adm. dir. of SOPHION BIOSCIENCE A/S.

SOPHION BIOSCIENCE A/S: The 2014 annual report is outJun 15, 2015

SOPHION BIOSCIENCE A/S has published its annual report for 2014.

About SOPHION BIOSCIENCE A/S

SOPHION BIOSCIENCE A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Michel Krall Jürgens. The company is owned by Sapphire Bioscience Holding ApS. The company has 41 employees. In 2025, the company reported a gross profit of DKK 102,112,000 and a net result of DKK 4,354,000 compared with DKK 39,127,000 the year before. Equity amounted to DKK 178,418,000.